drug

Trazodone

MeSH D014196
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by BeerYaakov Mental Health Center
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

2
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Treatment of Neuroleptic Induced Acute Akathisia With Trazodone
NCT00659919Phase 4Completed

KOLs & investigators

1
Helge Frieling, Prof., MDKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
BeerYaakov Mental Health Center
company
trial
Pharmacovigilance in Gerontopsychiatric Patients
PHASE3
trial
Treatment of Neuroleptic Induced Acute Akathisia With Trazodone
PHASE4
trial
indication
Schizophrenia
indication
Depression
indication
Psychosomatic Disorders
indication
Schizophrenia
indication
KOL
Helge Frieling, Prof., MD
KOL score 5
person